Academic Journal

Background parenchymal enhancement on breast MRI: A comprehensive review

التفاصيل البيبلوغرافية
العنوان: Background parenchymal enhancement on breast MRI: A comprehensive review
المؤلفون: Liao, Geraldine J., Henze Bancroft, Leah C., Strigel, Roberta M., Chitalia, Rhea D., Kontos, Despina, Moy, Linda, Partridge, Savannah C., Rahbar, Habib
المساهمون: National Cancer Institute
المصدر: Journal of Magnetic Resonance Imaging ; volume 51, issue 1, page 43-61 ; ISSN 1053-1807 1522-2586
بيانات النشر: Wiley
سنة النشر: 2019
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
الوصف: The degree of normal fibroglandular tissue that enhances on breast MRI, known as background parenchymal enhancement (BPE), was initially described as an incidental finding that could affect interpretation performance. While BPE is now established to be a physiologic phenomenon that is affected by both endogenous and exogenous hormone levels, evidence supporting the notion that BPE frequently masks breast cancers is limited. However, compelling data have emerged to suggest BPE is an independent marker of breast cancer risk and breast cancer treatment outcomes. Specifically, multiple studies have shown that elevated BPE levels, measured qualitatively or quantitatively, are associated with a greater risk of developing breast cancer. Evidence also suggests that BPE could be a predictor of neoadjuvant breast cancer treatment response and overall breast cancer treatment outcomes. These discoveries come at a time when breast cancer screening and treatment have moved toward an increased emphasis on targeted and individualized approaches, of which the identification of imaging features that can predict cancer diagnosis and treatment response is an increasingly recognized component. Historically, researchers have primarily studied quantitative tumor imaging features in pursuit of clinically useful biomarkers. However, the need to segment less well‐defined areas of normal tissue for quantitative BPE measurements presents its own unique challenges. Furthermore, there is no consensus on the optimal timing on dynamic contrast‐enhanced MRI for BPE quantitation. This article comprehensively reviews BPE with a particular focus on its potential to increase precision approaches to breast cancer risk assessment, diagnosis, and treatment. It also describes areas of needed future research, such as the applicability of BPE to women at average risk, the biological underpinnings of BPE, and the standardization of BPE characterization. Level of Evidence: 3 Technical Efficacy Stage: 5 J. Magn. Reson. Imaging 2020;51:43–61.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1002/jmri.26762
الاتاحة: http://dx.doi.org/10.1002/jmri.26762
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjmri.26762
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmri.26762
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jmri.26762
Rights: http://onlinelibrary.wiley.com/termsAndConditions#vor
رقم الانضمام: edsbas.87E9A923
قاعدة البيانات: BASE